U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse announces the availability of funding for implementation of the Neuroimmune Signaling and Function in Substance Use Disorders (R21) Exploratory/Developmental Research Grant. The purpose of this grant is to address the identification, characterization, and cellular responses of neuroimmune factors released from glial cells. The R21 activity code is intended to encourage new exploratory and developmental research projects. Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each Institute's grants management contact for this program . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | February 4, 2014

Federal Government Announces Neuroimmune Signaling and Function in Substance Use Disorders (R21) Exploratory/Developmental Research Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member